Martin van dent Bent, MD, PhD, shown wearing a lab coat

Martin van den Bent, MD, PhD

Neuro-oncologist

Specialties: Adult brain tumors, including glioma and glioblastoma

Dr. Martin J. van den Bent is a neuro-oncologist based in Rotterdam, who is internationally recognized for his expertise in the field. He has been the principal investigator of many international multicenter phase 2 and 3 trials on both high- and low-grade gliomas that contributed to the standard of care for patients with these brain tumors. From 2003 to 2009, Dr. Van Den Bent held the position of Chair of the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group, and between 2018 and 2020, he served as President of the European Association of Neuro-Oncology (EANO). 

Dr. van den Bent has served on several American Society for Clinical Oncology (ASCO) committees, including a committee on guidelines for molecular diagnostics in glioma. He has also written many chapters in textbooks on neuro-oncology and is one of the coordinating members of the Response Assessment in Neuro-Oncology (RANO) group. He is the recipient of several Society for Neuro-Oncology awards for Excellence in Clinical Research.

Education & Training

1975-1983: MD, Vrije Universiteit, Amsterdam, the Netherlands
1984: Resident, Neurology, Hervormd Diaconessenhuis, Arnhem, the Netherlands
1985-1988: Resident, Neurosurgery and Neurology, St. Lucas Ziekenhuis, Amsterdam, the Netherlands
1991: Resident, Clinical Neurophysiology, St Lucas Ziekenhuis, Amsterdam, the Netherlands
1994: PhD, Erasmus MC Rotterdam, the Netherlands

Academic Positions

1988-1990, 1992: Neurologist, St Lucas Ziekenhuis, Amsterdam, the Netherlands
1992-2002: Staff neurologist, Neuro-Oncology Unit, Daniel den Hoed Cancer Center/ Erasmus MC, Rotterdam, the Netherlands
2002-Present: Head Neuro-Oncology Unit Daniel den Hoed Cancer Center/ Erasmus MC, Rotterdam, the Netherlands
2006-Present: Professor in Neuro-Oncology, Erasmus University Rotterdam, the Netherlands 2025-Present: Professor, Neuro-Oncology, UCSF

Selected Awards

2024: Victor Levin Award, Society for Neuro-Oncology
2024: EANO Leadership Award
2024: Knight of the Order of the Lion of the Netherlands
2018: Award for Excellence in Adult Clinical Research, Society for Neuro-Oncology
2015: European CanCer Organisation Clinical Research Award
2014: Award for Excellence in Adult Clinical Research, Society for Neuro-Oncology
2004: Award for Excellence in Clinical Research, Society for Neuro-Oncology